DrugPatentWatch Database Preview
Zydus Pharms Usa Company Profile
» See Plans and Pricing
What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?
ZYDUS PHARMS USA has sixty approved drugs.
There are fifteen tentative approvals on ZYDUS PHARMS USA drugs.
Summary for Zydus Pharms Usa
| US Patents: | 0 |
| Tradenames: | 51 |
| Ingredients: | 51 |
| NDAs: | 60 |
Drugs and US Patents for Zydus Pharms Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | IRBESARTAN | irbesartan | TABLET;ORAL | 079213-003 | Sep 27, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms Usa Inc | IRBESARTAN | irbesartan | TABLET;ORAL | 079213-001 | Sep 27, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms Usa | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 077653-003 | Jun 13, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
